1. Home
  2. CDNA vs NUTX Comparison

CDNA vs NUTX Comparison

Compare CDNA & NUTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$20.58

Market Cap

712.2M

Sector

Health Care

ML Signal

HOLD

Logo Nutex Health Inc.

NUTX

Nutex Health Inc.

HOLD

Current Price

$184.98

Market Cap

729.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
NUTX
Founded
1998
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
712.2M
729.5M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
CDNA
NUTX
Price
$20.58
$184.98
Analyst Decision
Buy
Strong Buy
Analyst Count
7
2
Target Price
$26.00
$252.50
AVG Volume (30 Days)
816.3K
225.2K
Earning Date
11-04-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.22
17.98
Revenue
$357,998,000.00
$981,195,633.00
Revenue This Year
$14.11
$104.36
Revenue Next Year
$12.00
$4.10
P/E Ratio
$16.92
$10.29
Revenue Growth
14.46
236.03
52 Week Low
$10.96
$28.12
52 Week High
$25.95
$193.00

Technical Indicators

Market Signals
Indicator
CDNA
NUTX
Relative Strength Index (RSI) 71.98 66.64
Support Level $18.36 $107.09
Resistance Level $19.95 $187.20
Average True Range (ATR) 0.86 15.93
MACD 0.19 5.80
Stochastic Oscillator 99.42 87.38

Price Performance

Historical Comparison
CDNA
NUTX

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About NUTX Nutex Health Inc.

Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

Share on Social Networks: